Right Medication, Right Dose, Right Patient, Right Time, and Right Route: How Do We Select the Right Patient-Controlled Analgesia (PCA) Device?

Ladak, Salima; Chan, Vincent; Easty, Tony; Chagpar, Anjum

doi:10.1016/j.pmn.2007.08.001

Cited by 24 publications

(13 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this case, medical staff members missed three opportunities to detect the error. First, there was failure to do a double check during the device's setup 6‐8 . However, evidence for this practice is insufficient to support or refute its value 9 .…”

Section: Discussionmentioning

confidence: 99%

Death by PCA

2014

AORN Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Death by PCA

2014

AORN Journal

View full text Add to dashboard Cite

“…PCA education and training for the healthcare provider is necessary in order to reduce the human error associated with PCA (Cohen and Smetzer, 2005; Ferrell et al, 1992; Ladak et al, 2007). Inadequate training of nurses for acute intravenous PCA accounted for 12.9% of PCA errors in a large retrospective study ( n = 25,198) (Paul et al, 2010).…”

Section: Safety Of Pcamentioning

confidence: 99%

The role of patient-controlled analgesia in the management of chronic pain

Pergolizzi

Taylor

Muniz

2011

European Journal of Pain Supplements

View full text Add to dashboard Cite

Patient‐controlled analgesia (PCA) is a mainstay for postoperative and acute in‐hospital pain management. Its role in the chronic pain setting, for example for palliative care as well as the care of ambulatory patients with chronic pain syndromes, is not well defined. Acute PCA typically involves intravenous PCA using morphine, although other opioid analgesics may be used. Chronic PCA may take advantage of emerging PCA technologies including transmucosal and transdermal delivery systems, novel dispensing units for oral tablets, and device‐based therapies including implantable systems and external transcranial stimulation devices. Of particular concern in defining and developing chronic PCA systems are safety issues and concerns relating to long‐term opioid therapy, whether administered via PCA or in oral form by prescription. Since chronic pain populations are diverse, chronic PCA solutions—if appropriate at all—may vary. Chronic PCA has been studied in palliative care cancer patients, but other groups who might benefit from chronic PCA are less thoroughly investigated. Aim: This paper reviews the concept of the use of PCA as an option for the management of chronic pain in an appropriate patient population. It does so from the point of view of medical need, i.e., the optimal management of pain. We fully recognize, however, that there are also potential negatives and consequences that could arise from the point of view of misuse, abuse, and diversion. It is our hope that this paper stimulates not only a discussion of the use of PCA for chronic pain patients, but also a discussion about how best to balance medical need vs. inappropriate use.

show abstract

“…The quality dispensing practice of the pharmacists requires that an effective form of the correct medicines is delivered to the right patient, in the correct dosage and quantity, with clear instructions, and in a package that maintains the potency of the medicine [19][20][21][22]. When the request for a drug is made through a prescription, the pharmacist is positioned to accurately interpret the wishes of the prescriber.…”

Section: Introductionmentioning

confidence: 99%

Students’ Knowledge and Risk of Committing Medication Errors in Two Schools of Pharmacy in Nigeria

EKWE

Isah

et al. 2020

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Objective: The aim of this study was to determine the knowledge of prescription errors, the certainty of such knowledge, and the risk of committing medication errors among pharmacy students in two universities in Nigeria. Methods: This study was a cross-sectional comparative survey between pharmacy students of two universities in Nigeria: University of Nigeria, Nsukka (UNN) and Nnamdi Azikiwe University (NAU), Awka. Study variables were measured using four simulated prescriptions and questionnaires. Chi-square test, independent t-test, and ordinal regression analyses were used to assess study outcomes. Results: A total of 339 pharmacy students (239 in UNN and 100 in NAU), with a mean age of 24 (2.8) years and 57.2% (n=194) male students, participated in this study. Their accurate knowledge of each of the prescriptions were 294 (86.72%), 166 (48.97%), 199 (58.70%), and 248 (73.16%) for prescriptions with error of drug allergy, error of drug interaction, no error, and wrong dose of a drug, respectively. Students from UNN were more likely to commit a statistically significant high risk of error compared to NAU students in prescriptions with a drug allergy and wrong dose, while students in the 4th year class had a statistically significant higher odds of committing a drug interaction prescription error compared to final year students. Conclusion: Pharmacy students evaluated in this study had good knowledge of medication error detection. The risk of these pharmacy students committing a prescription error was evident in nearly all prescriptions tested and the students’ school was the major predictor of these risks.

show abstract

Right Medication, Right Dose, Right Patient, Right Time, and Right Route: How Do We Select the Right Patient-Controlled Analgesia (PCA) Device?

Cited by 24 publications

References 4 publications

Death by PCA

Death by PCA

The role of patient-controlled analgesia in the management of chronic pain

Students’ Knowledge and Risk of Committing Medication Errors in Two Schools of Pharmacy in Nigeria

Contact Info

Product

Resources

About